Castleview Partners’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Castleview Partners’s Portfolio KURE Stock Details KURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$70K	Buy	+1,540	New	+$65.5K	0.03%	346

Other funds holding KURE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MMFA

Main Management Fund Advisors San Francisco, California $1.41B AUM 22.53% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Leo Brokerage Hurst, Texas $876M AUM

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

MWM

Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return

Avestar Capital New York $1.79B AUM 33.8% 1-Year Est. Return

Castleview Partners's KURE Position: Q2 2021 in Review

Castleview Partners opened a new position in KraneShares MSCI All China Health Care Index ETF (KURE) in Q2 2021: 1,540 shares worth $70K. The stake represents 0.03% of the portfolio and ranks #346 among its holdings.

37 funds tracked by Wall St. Rank hold KURE as of Q2 2021.

Castleview Partners held 1,540 shares of KraneShares MSCI All China Health Care Index ETF worth $70K as of Q2 2021.
KraneShares MSCI All China Health Care Index ETF was a new Castleview Partners position in Q2 2021.
KraneShares MSCI All China Health Care Index ETF made up 0.03% of Castleview Partners's portfolio in Q2 2021, its #346 holding.
37 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.